Skip to main content

Roivant Sciences Ltd (ROIV) Insider Trading

In the last 90 days, 7 Roivant Sciences Ltd (ROIV) insiders reported no open-market purchases and 14 sales totaling $218,618,999. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Nov 17, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Nov 17, 2026Keith S ManchesterDirectorSale1,381,762$38.75$53,536,783
Nov 17, 2026Daniel Allen GoldDirectorSale1,381,762$38.75$53,536,783
Nov 17, 2026QVT Financial LPCorporate insiderSale1,381,762$38.75$53,536,783
Nov 11, 2026Richard PulikCFOSale300,000$41.58$12,473,280
Nov 10, 2026Eric VenkerPresident & Immunovant CEOSale187,943$40.53$7,617,067
Nov 3, 2026Eric VenkerPresident & Immunovant CEOSale200,000$36.31$7,262,000
Oct 28, 2026Eric VenkerPresident & Immunovant CEOSale200,000$36.59$7,318,000
Oct 20, 2026Eric VenkerPresident & Immunovant CEOSale200,000$35.11$7,022,660
Oct 1, 2026Melissa B EpperlyCorporate insiderSale17,750$36.10$640,860
Sep 30, 2026Eric VenkerPresident & Immunovant CEOSale200,000$36.62$7,324,000

Common questions

ROIV insider trading FAQ

Are ROIV insiders buying or selling?
Over the last 90 days, ROIV insiders were net sellers, reporting $0.00 of open-market purchases and $218,618,999 of sales.
When was the last ROIV insider purchase?
No open-market insider purchase of Roivant Sciences Ltd stock was reported in the last 90 days.
Where does ROIV insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Roivant Sciences Ltd officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.